NCT01643395

Brief Summary

The purpose of this protocol is to prove the efficacy of vertebroplasty in patients suffering from acute non osteoporotic vertebral compression fracture. Vertebroplasty consists in the injection of cement (PMMA) in the damaged vertebral body to prevent further collapse. Our study will compare vertebroplasty versus conservative therapy (brace).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2010

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 18, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

February 17, 2014

Status Verified

February 1, 2014

Enrollment Period

2.6 years

First QC Date

July 13, 2012

Last Update Submit

February 14, 2014

Conditions

Keywords

Traumavertebralcompression fracturespinalacutevertebroplastyconservative treatment

Outcome Measures

Primary Outcomes (1)

  • Disability scale

    at 1 month

Secondary Outcomes (2)

  • Spine radiological measurements

    at 1, 3 and 6 months

  • Disability and qol

    at 3 and 6 months

Study Arms (2)

vertebroplasty

EXPERIMENTAL
Other: vertebroplasty

conservative therapy (brace)

OTHER
Other: conservative therapy

Interventions

Vertebroplasty consists in the injection of cement (PMMA) in the damaged vertebral body to prevent further collapse

vertebroplasty

The study is a prospective, randomized trial comparing conservative treatment (brace) and vertebroplasty in acute (less than 15 days after trauma) traumatic vertebral compression fracture (VCF) type A according Magerl classification.

conservative therapy (brace)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • year old
  • volunteers
  • Vertebral compression fractures Magerl type A
  • Acute Trauma (less than 15 days)
  • Between T5 and L5
  • Patient able to undergo both vertebroplasty and conservative treatment
  • Consent form obtained

You may not qualify if:

  • Neural arch fracture
  • C1 to T4 fracture
  • Neurologic symptoms caused by the fracture
  • Encephalic trauma with Glasgow Coma Scale less than 15
  • Ongoing cancer
  • Routine painkillers intake
  • Local or systemic infection
  • Coagulation's disorder
  • Pregnancy
  • Involvement in an another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

Related Publications (1)

  • Chabert E, Hugonnet E, Kastler A, Sakka L, Rabbo FA, Zerroug A, Coudeyre E, Pereira B, Coll G. Vertebroplasty versus bracing in acute vertebral compression fractures: A prospective randomized trial. Ann Phys Rehabil Med. 2023 Sep;66(6):101746. doi: 10.1016/j.rehab.2023.101746. Epub 2023 Apr 6.

MeSH Terms

Conditions

Wounds and InjuriesFractures, Compression

Interventions

VertebroplastyConservative Treatment

Condition Hierarchy (Ancestors)

Fractures, Bone

Intervention Hierarchy (Ancestors)

CementoplastyOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Emmanuel CHABERT

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2012

First Posted

July 18, 2012

Study Start

September 1, 2010

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

February 17, 2014

Record last verified: 2014-02

Locations